Empresa Innate Immunotherapeutics Ltd Australian S.E.
Acciones
AU000000IIL6
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
AUD en millones | 2023 | Peso | 2024 | Peso | Delta |
---|---|---|---|---|---|
Focal Adhesion Kinase
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -63,46 % |
Ventas por región
AUD en millones | 2023 | Peso | 2024 | Peso | Delta |
---|---|---|---|---|---|
Australia
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -63,46 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | - | 31/05/00 | |
Tim Luscombe
DFI | Director of Finance/CFO | - | 25/09/23 |
Rhiannon Jones
COO | Chief Operating Officer | - | 01/02/21 |
Charlotte Mulder
PRN | Corporate Officer/Principal | - | - |
Mark Devlin
PRN | Corporate Officer/Principal | - | - |
Andrew Cooke
SEC | Corporate Secretary | 62 | 11/10/13 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Andrew Cooke
SEC | Corporate Secretary | 62 | 11/10/13 |
Robert Peach
BRD | Director/Board Member | 68 | 02/09/15 |
Warwick Tong
CHM | Chairman | - | 04/05/18 |
Founder | - | 31/05/00 | |
Jane Bell
BRD | Director/Board Member | - | 12/04/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 271 608 953 | 222 004 662 ( 81,74 %) | 0 | 81,74 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+11,91 % | 118 mil M | |
+11,60 % | 106 mil M | |
-4,68 % | 24,28 mil M | |
-0,82 % | 21,96 mil M | |
-10,12 % | 18,16 mil M | |
-42,12 % | 16,37 mil M | |
-17,47 % | 15,56 mil M | |
+2,77 % | 13,63 mil M | |
+34,58 % | 12,27 mil M |